European Commission nod for Novartis' Exjade

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or inade...Read more

CSL hemophilia therapy gets orphan drug status

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP), which can be used for the treatment of Hemophilia B, has been gran...Read more

John Vernachio is Arthritis Foundation research VP

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2013

Singapore: Arthritis Foundation appointed Dr John Vernachio as vice president of research, effective April 15. In his new role he will provide leadership and direction to further the Arthr...Read more

FDA gets biomarker database license from GVK Bio

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification Group of the US FDA. The Gobiom database, which has the latest and re...Read more

Otsuka, Lundbeck files NDA for schizophrenia drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

NIH study: Diabetes drug Metformin extends life

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age, reports an international team of scientists led...Read more

Accelerating drug discovery process

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2012

In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platforms to develop new drugs. Many biotechnology researchers and entreprene...Read more

Boehringer to open $46 mn biologics plant in Shanghai

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer contract manufacturing to Chinese companies developing their own drugs....Read more

Recycled plastic can kill drug-resistant fungi

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research Almaden have discovered a new, potentially life-saving application f...Read more

Novartis liver cancer trial with Afinitor flops

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not extend overall survival as compared to placebo in patients with locall...Read more

Oramed submits pre-IND for exenatide to FDA

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (pre-IND) meeting request to the US FDA for a US-based trial on its or...Read more

Aussie drug delivery firm raises $19.3 mn

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to institutional and sophisticated investors in Europe, USA, Asia and A...Read more

Bayer initiates Phase II/III trial of a new compound for Hemophilia A

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hem...Read more

APAC ovarian cancer drug market to grow modestly'

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more

Deal with Janssen gets Astellas $65 million up-front

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2012

Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to develop and commercialize ASP015K, an Astellas compound, worldwide e...Read more

Lorcaserin receives positive vote from FDA advisory committee

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 18 to four, with one abstention, at a meeting held on ...Read more

Biodiem gets US patent allowance for antifungal therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowance of a new US divisional patent from US Patent and Trademark Office, ...Read more

Minoryx Therapeutics receives Orphan Drug Designation for its lead candidate MIN-102

Drug Discovery |  News | 0 Comment | 22 Feb, 2017

Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan diseases, today announces that its lead compound MIN-102 has been grant...Read more